Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Tolerability, Safety, and Effectiveness of Ofatumumab in Adults With Multiple Sclerosis Over 36 Months

Real-world Experience With Ozanimod at Two Academic Multiple Sclerosis Centers With Expanded 24-month Data

Real World Clinical Experience from ENABLE, the First Phase Four Observational Study for Patients With Relapsing Multiple Sclerosis Initiating Ublituximab